Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于局部晚期或转移性胰腺癌的研究。
货号:ajcx35702
CAS:1983983-41-0
分子式:C13H11N7O
分子量：281.27
溶解度:N/A
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Avotaciclib (BEY1107) is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib can be used for the research of locally advanced or metastatic pancreatic cancer[1].

[1]. Seufferlein T, et, al. Phase I Trials in Pancreatic Cancer. Translational Pancreatic Cancer Research pp 219-232.